NCT02399657View on ClinicalTrials.gov

Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema

PHASE4UnknownINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Diabetes MellitusMacular EdemaRetinal Exudates and Deposits
Interventions
DRUG

Intravitreal dexamethasone 0.7mg implant

Ozurdex at day 0 (fixed), 5 months (fixed), 10 months pro re nata or 11 months pro re nata

Trial Locations (8)

660-702

RECRUITING

Gyeongsang National University Hospital, Jinju

602-702

RECRUITING

Kosin University Gospel Hospital, Busan

602-715

RECRUITING

Dong-A University hospital, Busan

602-739

RECRUITING

Pusan national university hospital, Busan

612-030

RECRUITING

Inje University Haeundae Paik hospital, Busan

614-735

RECRUITING

Inje University Busan Paik hospital, Busan

700-721

RECRUITING

Kyungpook National University Hospital, Daegu

705-717

RECRUITING

Yeungnam University Medical Center, Daegu

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Inje University

OTHER